Comparing Sharps Technology (STSS) & Its Peers

Sharps Technology (NASDAQ:STSS) is one of 234 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Sharps Technology to similar businesses based on the strength of its dividends, profitability, risk, institutional ownership, analyst recommendations, valuation and earnings.

Institutional & Insider Ownership

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 48.2% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 12.6% of Sharps Technology shares are held by company insiders. Comparatively, 15.3% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Sharps Technology and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-102.25%	-72.97%
Sharps Technology Competitors	-673.58%	-130.39%	-27.84%

Volatility and Risk

Sharps Technology has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, Sharps Technology’s competitors have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Sharps Technology and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	0	0	0	0	N/A
Sharps Technology Competitors	1718	4537	8703	237	2.49

As a group, “Surgical & medical instruments” companies have a potential upside of 25.12%. Given Sharps Technology’s competitors higher probable upside, analysts plainly believe Sharps Technology has less favorable growth aspects than its competitors.

Valuation & Earnings

This table compares Sharps Technology and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sharps Technology	N/A	-$9.84 million	-0.35
Sharps Technology Competitors	$1.02 billion	$3.49 million	-4,613.29

Sharps Technology’s competitors have higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Sharps Technology competitors beat Sharps Technology on 6 of the 10 factors compared.

Sharps Technology Company Profile

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.